Potential medicinal plants involved in inhibiting 3CL^(pro) activity:A practical alternate approach to combating COVID-19

查看全文 作　　者：Fan [1]Yang;Xiao-lan [1]Jiang;Akash [2]Tariq;Sehrish [3]Sadia;Zeeshan [2]Ahmed;Jordi [4,5]Sardans;Muhammad [3]Aleem;Riaz [6]Ullah;Rainer [7]W.Bussmann

机构地区：[1]The Medical Center of General Practice,Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital,Chengdu 610041,Sichuan Province,China;[2]Xinjiang Institute of Ecology and Geography,Chinese Academy of Sciences,Urumqi 830041,Xinjiang Uygur Autonomous Region,China;[3]Department of Biological Sciences,University of Veterinary and Animal Sciences,Ravi Campus,Pattoki 55300,Pakistan;[4]Consejo Superior de Investigaciones Científicas,Global Ecology Unit,Centre for Ecological Research and Forestry Applications-Consejo Superior de Investigaciones Científicas-Universitat Autònoma de Barcelona,Bellaterra,08193 Barcelona,Catalonia,Spain;[5]Centre for Ecological Research and Forestry Applications,Cerdanyola del Vallès 08193,Catalonia,Spain;[6]Department of Pharmacognosy,College of Pharmacy,King Saud University,Riyadh 11451,Saudi Arabia;[7]Department of Ethnobotany,Institute of Botany,llia State University,Tbilisi 0105,Georgia

出　　处：《Journal of Integrative Medicine》索引2022年第20卷第6期,共9页

基　　金：financially supported by President’s International Fellowship Initiative(PIFI)for Postdoctoral Researchers,Chinese Academy of Sciences(No.2020PB0002),China。 摘　　要：At present,a variety of vaccines have been approved,and existing antiviral drugs are being tested to find an effective treatment for coronavirus disease 2019(COVID-19).However,no standardized treatment has yet been approved by the World Health Organization.The virally encoded chymotrypsin-like protease(3CL^(pro))from severe acute respiratory syndrome coronavirus 2(SARS-CoV-2),which facilitates the replication of SARS-CoV in the host cells,is one potential pharmacological target for the development of antiSARS drugs.Online search engines,such as Web of Science,Google Scholar,Scopus and PubMed,were used to retrieve data on the traditional uses of medicinal plants and their inhibitory effects against the SARS-CoV 3CL^(pro).Various pure compounds,including polyphenols,terpenoids,chalcones,alkaloids,biflavonoids,flavanones,anthraquinones and glycosides,have shown potent inhibition of SARS-CoV-2 3CL^(pro) activity with 50% inhibitory concentration(IC_(50))values ranging from 2-44μg/mL.Interestingly,most of these active compounds,including xanthoangelol E(isolated from Angelica keiskei),dieckol 1(isolated from Ecklonia cava),amentoflavone(isolated from Torreya nucifera),celastrol,pristimerin,tingenone and iguesterin(isolated from Tripterygium regelii),tannic acid(isolated from Camellia sinensis),and theaflavin-3,3’-digallate,3-isotheaflav1in-3 gallate and dihydrotanshinone I(isolated from Salvia miltiorrhiza),had IC_(50)values of less than 15μg/mL.Kinetic mechanistic studies of several active compounds revealed that their mode of inhibition was dose-dependent and competitive,with K_(i)values ranging from 2.4-43.8μmol/L.Given the significance of plant-based compounds and the many promising results obtained,there is still need to explore the phytochemical and mechanistic potentials of plants and their products.These medicinal plants could serve as an effective inexpensive nutraceutical for the general public to help manage COVID-19. 关键词：COVID-19 SARS-CoV-2 Coronavirus 3C proteases Medicinal plants Plant-derived compounds Drug development

相关文献

参考文献（82）
引证文献（0）
耦合文献（51）

参考文献(82)

耦合文献(51)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Potential medicinal plants involved in inhibiting 3CL^(pro) activity:A practical alternate approach to combating COVID-19

参考文献(82)

耦合文献(51)

用户提示